Luigi Mangione is expected to plead guilty in his federal stalking case related to the 2024 killing of UnitedHealthcare CEO Brian Thompson in Manhattan. The plea is scheduled during a pretrial conference in U.S. District Court, while Mangione also faces state murder charges for the same incident. If he pleads guilty federally, his defense may argue that double jeopardy laws prevent state murder prosecution. Jury selection for the state case is set for September, with the federal trial slated for January.
Luigi Mangione pleaded guilty in a New York federal court to stalking that led to the killing of UnitedHealthcare CEO Brian Thompson in December 2024. His plea came just weeks before a state trial for Thompson's murder was set to begin. Mangione face...
The Schwab U.S. Dividend Equity ETF (SCHD) focuses on high-quality companies with strong financials and a history of growing dividends, rather than chasing the highest yields. While its yield is around 3% to 4%, SCHD has delivered strong long-term re...
In 2026, the Schwab U.S. Dividend Equity ETF (SCHD) leads with a 25.6% year-to-date return, driven by its focus on current yield, value sectors, and energy exposure. Meanwhile, the Vanguard Dividend Appreciation ETF (VIG) prioritizes dividend growth ...
Over the past decade, iShares Core Dividend Growth ETF (DGRO) returned 257.35%, outperforming Schwab US Dividend Equity ETF (SCHD) which returned 235.33%. The difference stems from SCHD's stricter stock selection criteria requiring 10 years of consec...
In 2024, Schwab U.S. Dividend Equity ETF (SCHD) experienced a major index reshuffle that led to unusually high distributions, nearly tripling the typical quarterly amount. This caused significant tax liabilities for investors holding SCHD in taxable ...
